“Richard is always highly responsive, commercially switched on and receptive to the needs of your business.” IAM Patent 1000 2025

“Richard is responsive, knowledgeable, and outstanding when drafting and negotiating complex agreements.” WTR 1000 2025

"Richard has an extraordinary ability to explain complicated issues in a succinct and easy manner." Chambers and Partners 2025

"The practice is jointly led by Richard Dickinson, who possesses particular capabilities in the media and entertainment, consumer products, and retail industries..." Legal 500 2025

“Dickinson captains the team and is hugely experienced when it comes to drawing up cross-border deals. His logical and practical advice and astute commercial acumen make him a hit with his following.” IAM Patent 1000 2024

“Richard makes really valuable contributions to pharmaceutical licensing discussions. He is pragmatic, business oriented and readily available when needed.” IAM Patent 1000 2023

“Richard Dickinson is a very good lawyer - very commercial and good with clients.” Chambers and Partners 2023

“Richard Dickinson has a wide and varied transactional practice assisting large corporate clients with licence agreements and disputes. He has experience advising clients in various industries including life sciences, media and retail.” Chambers and Partners 2023

“Richard Dickinson is strong on non-patent intellectual property matters and media-related work.” Chambers and Partners 2022

“Dickinson’s academic background is in biochemistry, though his industry expertise is far broader, thanks to having negotiated cross-border IP transactions for 25 years.” IAM Patent 1000 2022

“Bristows was a valued partner in the success of making our vision become a reality.” Stephanie Morris, Director of Industry Partnerships and Commercialisation at Imperial College London

“They enabled a very positive conclusion to the overall deal.” Richard Fagan, Director of BioPharma at UCL Business

“Their expertise made them the perfect partner to work with on the highly complex Apollo transaction.” Richard Fagan, Director of BioPharma at UCL Business

“UCLB has worked with Bristows for over 25 years, in relation to intellectual property licensing transactions as well as corporate transactions such as spinout formation.” Richard Fagan, Director of BioPharma at UCL Business

“Bristows’ knowledge of the life sciences market and players, as well as their licensing expertise, was invaluable as we navigated this complex transaction.” Iain Thomas, Cambridge Enterprise’s Head of Life Sciences